颅内动脉瘤术后他汀治疗与预后关联的回顾性队列研究
该研究基于韩国国民健康保险服务样本队列数据库,纳入2002至2013年间接受弹簧圈栓塞或手术夹闭的1381例颅内动脉瘤患者。随访期间335例(24.3%)发生主要结局,持续他汀治疗(PDC>80%)与主要结局风险降低显著相关(校正HR 0.34,95%CI 0.14-0.85)。
要点
- 持续他汀治疗(PDC>80%)与动脉瘤术后主要结局风险降低独立相关。
- 主要结局为卒中、心肌梗死和全因死亡的复合终点。
- 研究为回顾性队列,他汀治疗依据处方索赔计算PDC,非随机分组。
核心结论
- 持续他汀治疗与弹簧圈栓塞或手术夹闭后更好的预后显著相关(校正HR 0.34,95%CI 0.14-0.85)。
研究设计与样本
- 回顾性队列研究,使用韩国国民健康保险服务国家样本队列数据库。
- 纳入2002至2013年因颅内动脉瘤行弹簧圈栓塞(n=542)或手术夹闭(n=839)的患者共1381例。
- 以随访期间他汀处方覆盖天数比例(PDC)作为他汀治疗标志,采用多因素时依Cox回归分析。
主要发现
- 平均随访3.83±3.35年,335例(24.3%)发生主要结局(卒中、心肌梗死和全因死亡的复合终点)。
- 持续他汀治疗(PDC>80%)与主要结局风险降低显著相关(校正HR 0.34,95%CI 0.14-0.85)。
- 校正变量包括性别、年龄(连续变量)、治疗方式、动脉瘤破裂状态、高血压、糖尿病、家庭收入水平、既往缺血性卒中或脑出血史及随访期他汀治疗。
临床怎么用
- 对于接受弹簧圈栓塞或手术夹闭的颅内动脉瘤患者,持续他汀治疗(PDC>80%)可能与更好的预后相关。
- 该结果为回顾性关联,不能直接推导他汀的治疗指征,需结合个体情况权衡。
局限性
- 回顾性队列设计,他汀治疗基于处方索赔计算PDC,可能存在未测量的混杂因素。
- 原文摘要未报告具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cerebral aneurysms represent the most common cause of spontaneous subarachnoid hemorrhage. Statins are lipid-lowering agents that may expert multiple pleiotropic vascular protective effects. The authors hypothesized that statin therapy after coil embolization or surgical clipping of cerebral aneurysms might improve clinical outcomes. METHODS: This was a retrospective cohort study using the National Health Insurance Service-National Sample Cohort Database in Korea. Patients who underwent coil embolization or surgical clipping for cerebral aneurysm between 2002 and 2013 were included. Based on prescription claims, the authors calculated the proportion of days covered (PDC) by statins during follow-up as a marker of statin therapy. The primary outcome was a composite of the development of stroke, myocardial infarction, and all-cause death. Multivariate time-dependent Cox regression analyses were performed. RESULTS: A total of 1381 patients who underwent coil embolization (n = 542) or surgical clipping (n = 839) of cerebral aneurysms were included in this study. During the mean (± SD) follow-up period of 3.83 ± 3.35 years, 335 (24.3%) patients experienced the primary outcome. Adjustments were performed for sex, age (as a continuous variable), treatment modality, aneurysm rupture status (ruptured or unruptured aneurysm), hypertension, diabetes mellitus, household income level, and prior history of ischemic stroke or intracerebral hemorrhage as time-independent variables and statin therapy during follow-up as a time-dependent variable. Consistent statin therapy (PDC > 80%) was significantly associated with a lower risk of the primary outcome (adjusted hazard ratio 0.34, 95% CI 0.14-0.85). CONCLUSIONS: Consistent statin therapy was significantly associated with better prognosis after coil embolization or surgical clipping of cerebral aneurysms.
引用
- Song TJ, Oh SH, Kim J, et al. The impact of statin therapy after surgical or endovascular treatment of cerebral aneurysms. J Neurosurg. 2019. PMID: 31125972. doi:10.3171/2019.3.JNS183500
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。